Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

Lancet

Volumn 349, Issue 9050, 1997, Pages 458-461

  Beresford, Shirley A A ^a,b   Weiss, Noel S ^a   Voigt, Lynda F ^a   McKnight, Barbara ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; UNITED STATES;

EID: 0031058448     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07365-5     Document Type: Article

References (23)

1. Whitehead MI, Hillard TC, Crook D. The role and use of progestogens. J Obstet Gynaecol 1990; 75: 59-76 (suppl).
2. Whitehead MI, Townsend PT, Pryse-Davis J, et al. Effects of estrogens and progestagen on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981; 305: 1599-605.
3. Sturdee DN, Wade-Evans T, Peterson MEL, et al. Relations between bleeding pattern, endometrial histology, and estrogen treatment in menopausal women. BMJ 1978: i: 1575-77.
4. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 1996; 275: 370-75.
5. Brinton LA, Hoover RN. The endometrial cancer collaborative group. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. J Obstet Gynecol 1993; 81: 265-71.
6. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274-77.
7. Jick SS, Walker AM, Jick H. Estrogens, progesterone, and endometrial cancer. Epidemiology 1993; 4: 20-24.
8. Jick SS. Combined estrogen and profesterone use and endometrial cancer. Epidemiology 1993; 4: 384.
9. Psaty BM, Heckbert SR, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestagens in postmenopausal women. Arch Intern Med 1994; 154: 1333-39.
10. Ernster VL, Bush TL, Huggins GR, Hulka BS, Kelsey JL, Schottenffeld D. Benefits and risks of menopausal estrogen and/or progestagen hormone use. Prev Med 1988; 17: 201-23.
11. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestagen regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestagen Trial. JAMA 1995; 273: 199-208.
12. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978; 73: 40-46.
13. Beresford SAA, Coker AL. Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol 1989; 130: 202-05.
14. Voigt LF, Davis S, Heuser L. Random digit dialing: the potential effect on sample characteristics of the conversion of non-residential phone numbers. Am J Epidemiol 1992; 136: 1393-99.
15. Genalo MA, Hickman RD. A study of ring/no answer numbers in random digit dialing telephone surveys. Proceedings of the Section on Survey Research Methods of the American Statistical Association. Alexandria: American Statistical Association, 1988: 552-57.
16. Breslow NE, Day NE. The analysis of case control studies, volume 1. Lyons: International Agency for Research on Cancer, 1980.
17. Whitehead MI, Fraser D. The effects of estrogens and progestogens on the endometrium. Obstet Gynecol Clin North Am 1987; 14: 299-320.
18. Gambrell RD, Massey FM, Castaneda T A, Ugenas AJ, Ricci C A, Wright JM. Use of the progestogen challenge test to reduce the risk of endometrial cancer. J Obstet Gynaecol 1980; 55: 732-38.
19. Hammond CB, Jelovsek FR, Lee KL, et al. Effect of long-term estrogen replacement therapy. Am J Obstet Gynecol 1979; 133: 537-47.
20. Stadel BV, Weiss N. Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-1974. Am J Epidemiol 1975; 102: 209-16.
21. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114-22.
22. Persson I, Bergkvist L, Adami H. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987; 16: 222-28.
23. Robinson D, Friedman L, Marcus R, Tinkleberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994; 42: 919-22.